PDL Biopharma
PDLI
#8044
Rank
NZ$0.48 B
Marketcap
NZ$4.26
Share price
-8.52%
Change (1 day)
N/A
Change (1 year)

Market capitalization of PDL Biopharma (PDLI)

Last known market cap: NZ$0.48 Billion

As of December 2025 PDL Biopharma has a market cap of NZ$0.48 Billion. This makes PDL Biopharma the world's 8044th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of PDL Biopharma from 2001 to 2021

End of year Market Cap

Year Marketcap Change
2021NZ$0.41 B5.64%
2020NZ$0.39 B-34.71%
2019NZ$0.59 B1.48%
2018NZ$0.59 B-0.88%
2017NZ$0.59 B17.53%
2016NZ$0.50 B-40.38%
2015NZ$0.84 B-46.76%
2014NZ$1.59 B11.04%
2013NZ$1.43 B20.12%
2012NZ$1.19 B7.71%
2011NZ$1.11 B-1.49%
2010NZ$1.12 B-0.11%
2009NZ$1.12 B-11.3%
2008NZ$1.27 B-52.68%
2007NZ$2.68 B-18.2%
2006NZ$3.28 B-29.44%
2005NZ$4.65 B67.89%
2004NZ$2.77 B7.35%
2003NZ$2.58 B78.49%
2002NZ$1.44 B-79.36%
2001NZ$7.01 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Compugen
CGEN
NZ$0.24 B-48.95%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
NZ$307.92 B 63,147.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
NZ$1.52 B 213.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$1.664 T 341,830.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
NZ$0.26 B-45.11%๐Ÿ‡บ๐Ÿ‡ธ USA